Skip to main content

Advertisement

SpringerLink
Log in

Effect of Gabapentin on Swallowing During and After Chemoradiation for Oropharyngeal Squamous Cell Cancer

  • Original Article
  • Published:
Dysphagia Aims and scope Submit manuscript

An Erratum to this article was published on 04 May 2014

Abstract

The aim of this study was to examine the impact of gabapentin (neurontin) on swallowing and feeding tube use during chemoradiation (CRT) for oropharyngeal squamous cell carcinoma (OPSCC), and physiologic swallowing outcomes following completion of treatment. A total of 23 patients treated for OPSCC with concurrent CRT and prophylactically treated for pain using gabapentin were assessed. Historical controls were matched for T stage and primary site of disease. Timing of PEG use and removal were recorded. Video fluoroscopic swallowing studies were completed post-treatment to assess physiologic outcomes as well as penetration–aspiration scores (PAS). Functional oral intake scale (FOIS) scores were determined at the time of swallowing evaluation to assess diet level. Patients treated with gabapentin began using their PEG tubes later (3.7 vs. 2.29 weeks; P = 0.013) and had their PEG tubes removed earlier (7.29 vs. 32.56 weeks; P = 0.039) than the historical controls. A number of physiologic parameters were found to be less impacted in the gabapentin group, including oral bolus control (P = 0.01), epiglottic tilt (P = 0.0007), laryngeal elevation (P = 0.0017), and pharyngeal constriction (P = 0.002). PAS scores were significantly lower in the group treated with gabapentin (1.89 vs. 4; P = 0.0052). Patients receiving gabapentin had more advanced diet levels at the time of the initial swallowing study as evidenced by their FOIS scores (5.4 vs. 3.21; P = 0.0003). We conclude that patients using gabapentin for pain management during CRT appears to do well maintaining swallow function during treatment and have favorable post-treatment physiologic swallowing outcomes. Prospective evaluation is warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324(24):1685–90.

    Article  Google Scholar 

  2. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349(22):2091–8.

    Article  CAS  PubMed  Google Scholar 

  3. Gillespie M, Brodsky MB, Day TA, Sharma AK, Lee F, Martin-Harris B. Laryngeal penetration and aspiration during swallowing after the treatment of advanced oropharyngeal cancer. Arch Otorhinolaryngol Head Neck Surg. 2005;131:615–9.

    Article  Google Scholar 

  4. Elting LS, Keefe DM, Sonis ST, et al. Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. Cancer. 2008;113(10):2704–13.

    Article  PubMed  Google Scholar 

  5. Trotti A, Bellm LA, Epstein JB, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol. 2003;66(3):253–62.

    Article  PubMed  Google Scholar 

  6. Murphy BA, Beaumont JL, Isitt J, et al. Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy. J Pain Symptom Manage. 2009;38(4):522–32.

    Article  PubMed  Google Scholar 

  7. Langmore S, Krisciunas GP, Miloro KV, et al. Does PEG use cause dysphagia in head and neck cancer patients? Dysphagia. 2012;27(2):251–9.

    Article  PubMed  Google Scholar 

  8. Kotz T, Costello R, Li Y, Posner MR. Swallowing dysfunction after chemoradiation for advanced squamous cell carcinoma of the head and neck. Head Neck. 2004;26(4):365–72.

    Article  PubMed  Google Scholar 

  9. Graner DE, Foote RL, Kasperbauer JL, et al. Swallow function in patients before and after intra-arterial chemoradiation. Laryngoscope. 2003;113(3):573–9.

    Article  PubMed  Google Scholar 

  10. Lazarus C. Tongue strength and exercise in healthy individuals and head and neck cancer patients. Semin Speech Lang. 2006;27(4):260–7.

    Article  PubMed  Google Scholar 

  11. Starmer H, Gourin C, Lua LL, Burkhead L. Pretreatment swallowing assessment in head and neck cancer patients. Laryngoscope. 2011;121(6):1208–11.

    Article  PubMed  Google Scholar 

  12. Maneuf YP, Luo ZD, Lee K. α2δ and the mechanism of action of gabapentin in the treatment of pain. Semin Cell Dev Biol. 2006;17:565–70.

    Article  CAS  PubMed  Google Scholar 

  13. Luo ZD, Chaplan SR, Higuera ES, et al. Upregulation of dorsal root ganglion α2δ calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J Neurosci. 2001;21:1868–75.

    CAS  PubMed  Google Scholar 

  14. Li CY, Song YH, Higuera ES, et al. Spinal dorsal horn calcium channel α2δ-1 subunit upregulation contributes to peripheral nerve injury-induced tactile allodynia. J Neurosci. 2004;24:8494–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Boroujerdi A, Kim HK, Lyu YS, et al. Injury discharges regulate calcium channel alpha-2-delta-1 subunit upregulation in the dorsal horn that contributes to initiation of neuropathic pain. Pain. 2008;139:358–66.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Luo Z, Calcutt N, Higuera E, et al. Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J Pharmacol Exp Ther. 2002;303:1199–205.

    Article  CAS  PubMed  Google Scholar 

  17. Bar Ad V, Weinstein G, Dutta PR, et al. Gabapentin for the treatment of pain related to radiation-induced mucositis in patients with head and neck tumors treated with intensity-modulated radiation therapy. Head Neck. 2010;32:173–7.

    PubMed  Google Scholar 

  18. Bar Ad V, Weinstein G, Dutta PR, et al. Gabapentin for the treatment of pain syndrome related to radiation-induced mucositis in patients with head and neck cancer treated with concurrent chemoradiotherapy. Cancer. 2010;116:4206–13.

    Article  PubMed  Google Scholar 

  19. Rosenbek J, Robbins J, Roecker E, Coyle J, Wood J. A penetration aspiration scale. Dysphagia. 1996;11(2):93–8.

    Article  CAS  PubMed  Google Scholar 

  20. Crary MA, Mann GD, Groher ME. Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients. Arch Phys Med Rehabil. 2005;86(8):1516–20.

    Article  PubMed  Google Scholar 

  21. Epstein JB, Wilkie DJ, Fisher DJ, et al. Neuropathic and nociceptive pain in head and neck cancer patients receiving radiation therapy. Head Neck Oncol. 2009;1:26.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Carnaby-Mann G, Crary MA, Schmalfuss I, Amdur R. “Pharyngocise”: randomized controlled trial of preventative exercises to maintain muscle structure and swallowing function during head and neck chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2012;83(1):210–9.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors have no conflicts of interest or financial ties to disclose.

Author information

Authors and Affiliations

  1. Johns Hopkins Outpatient Center, Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Medical Institutions, 601 N. Caroline Street, Suite 6260, Baltimore, MD, 21287, USA

    Heather M. Starmer & Christine G. Gourin

  2. Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins Medical Institutions, Baltimore, MD, USA

    WuYang Yang, Raju Raval, Marian Richardson, Rachit Kumar, Todd McNutt, Sierra Cheng & Harry Quon

  3. Department of Radiology, Johns Hopkins Medical Institutions, Baltimore, MD, USA

    Bronwyn Jones

Authors
  1. Heather M. Starmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. WuYang Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Raju Raval
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christine G. Gourin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marian Richardson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rachit Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bronwyn Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Todd McNutt
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Sierra Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Harry Quon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Heather M. Starmer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Starmer, H.M., Yang, W., Raval, R. et al. Effect of Gabapentin on Swallowing During and After Chemoradiation for Oropharyngeal Squamous Cell Cancer. Dysphagia 29, 396–402 (2014). https://doi.org/10.1007/s00455-014-9521-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00455-014-9521-1

Keywords

Search

Navigation